|
|
|
|
Clinical Cancer Investigation Journal [ISSN:2278-0513], a publication of Middle-Eastern Association for Cancer Research (MEACR), is a double-blind peer-reviewed online journal with quarterly print on demand compilation of issues published. The journal's full text is available online at http://www.ccij-online.org. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository. The journal does not charge for submission, processing of manuscripts and even for color reproduction of photographs.
Publishing frequency: Bimonthly/6 issues per year
Abstracting and Indexing Information
The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), Ex Libris Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TDNet, Wanfang Data
The journal is indexed with, or included in, the following:
Embase, Index Copernicus, EBSCO Publishing's Electronic Databases, CAS Source Index.
Aim and Scope
The Clinical Cancer Investigation Journal is a double-blind peer-reviewed publication dedicated to advancing the understanding and treatment of cancer through rigorous clinical research. Our journal provides a platform for the dissemination of high-quality, innovative studies spanning various aspects of cancer diagnosis, prognosis, therapy, and survivorship. We welcome the knowledge base of cancer biology, pathology, genetics, immunology, and therapeutic interventions. With a commitment to excellence and relevance in the field of oncology, our mission is to foster collaboration among researchers and clinicians worldwide, ultimately striving towards improved outcomes for cancer patients.
Announcement and Advertisement
Announcements regarding scientific activities such as conferences, symposium, are published for free. Advertisements can be either published or placed on website as banners.
|
||||||||
